MedPath

AK-FLUOR

These highlights do not include all the information needed to use AK-FLUOR 10% and AK-FLUOR 25% safely and effectively. See full prescribing information for the products in AK-FLUOR 10% and AK-FLUOR 25%. AK-FLUOR (fluorescein injection, USP) 10% and AK-FLUOR (fluorescein injection, USP) 25%Intravenous injection Initial U.S. Approval: 1976

Approved
Approval ID

e18fb095-d580-433c-88c5-f234f509a00f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 15, 2021

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

fluorescein sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-4535
Application NumberNDA022186
Product Classification
M
Marketing Category
C73594
G
Generic Name
fluorescein sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 15, 2016
FDA Product Classification

INGREDIENTS (4)

sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
FLUORESCEIN SODIUMActive
Quantity: 100 mg in 1 mL
Code: 93X55PE38X
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.